PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Unit of Internal Medicine, Department of Medicine, Hospital \'Santa Maria Della Misericordia\', University of Perugia, Piazzale Menghini, 1, 06129, Perugia, Italy.\', \'Department of Clinical, Internal Medicine and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.\', \'Unit of Pharmacology, Department of Experimental Medicine, University of Perugia, Perugia, Italy.\', \'Halal Research Center of IRI, FDA, Tehran, Iran.\', \'Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.\', \'Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.\', \'Unit of Internal Medicine, Department of Medicine, Hospital \'Santa Maria Della Misericordia\', University of Perugia, Piazzale Menghini, 1, 06129, Perugia, Italy. matteo.pirro@unipg.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s40265-020-01365-1
?:hasPublicationType
?:journal
  • Drugs
is ?:pmid of
?:pmid
?:pmid
  • 32705604
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.547
?:rankingScore_hIndex
  • 150
is ?:relation_isRelatedTo_publication of
?:title
  • Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all